ALFA Finder| Revenue growth | 38.2% YoY reported; 40.0% YoY on LFL basis. |
|---|---|
| Margins | Gross margin up 147bps to 11.4%; EBITDA margin reached 5.0%. |
| Demand visibility | Organic growth running ahead of IPM growth. |
| Management confidence | High confidence on delivering on guidance for rest of the year. |
Growth
Revenue rose 38% YoY; EBITDA increased 94% to ₹97 Cr; PAT (to owners) grew 37% to ₹38.2 Cr.
Outlook
MedTech revenue expected to cross ₹1,000 Cr in FY27. High confidence in delivering on guided trajectory.
Risks
Fragmented market competition and potential impact from conscious exits in certain low-margin businesses.
Last quarter's promises, checked
Delivered
- Guided 30% LFL revenue growth → delivered 31.5% (= BEAT)
- Guided 4% EBITDA margin → delivered 4% (= BEAT)
- Guided operating cash flow optimization → delivered ₹96.2 Cr OCF (= BEAT)
Investor Presentation filed with BSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹2,019.10
- Market cap
- ₹8,796 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 63.1×Sector 54.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Legal & Regulatory
Entero's subsidiary Vasavi Medicare faces an INR 11.87 crore customer default. Vasavi has fully provided for the dues and plans legal recovery action.
- Value
- ₹11.87 Cr
Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Q2 FY27 Results: Net Profit ₹60.7 Cr, Up 65.8% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹2,087 Cr (+32.9% YoY) and net profit of ₹60.7 Cr (+65.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.7 Cr · +65.8% YoY
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.